Hi Pivalde
Do you know the answer to this ?
From the article crucible
I can’t work this out ?
“The results also showed “preservation of brain volume”.Somewhat oddly, the 75mg dose showed a 62% slowing at week-26, but only a 29% response at week-52.Nor surprisingly, the company is pondering the discrepancy.Nonetheless, Stamler says the company is “thrilled that ATH-434 has demonstrated significant slowing of clinical progression and an excellent safety profile in this rare, rapidly progressive disease.”
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $147.3M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.8¢ | 1.5¢ | $743.0K | 46.08M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 9557196 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 3866770 | 10 |
View Market Depth
| Last trade - 11.50am 28/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |